Keyphrases
Observational Cohort Study
100%
Pediatric
100%
Obese Patients
100%
Unfractionated Heparin
100%
Actual Weight
100%
Anti-FXa
100%
Dose Capping
100%
Supratherapeutic
66%
Body Mass Index
33%
Clinically Significant
33%
Bleeding Rate
33%
Pediatric Population
33%
Dosing Strategy
33%
Pediatric Research
33%
Index-based
33%
Non-majors
33%
Weight-based
33%
Heparin Dosing
33%
Weight Categories
33%
Medicine and Dentistry
Cohort Study
100%
Pediatrics
100%
Heparin
100%
Body Weight
100%
Capping Phenomenon
100%
Body Mass Index
33%
Bleeding
33%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Body Weight
100%
Heparin
100%
Capping Phenomenon
100%
Body Mass
50%
Nursing and Health Professions
Cohort Analysis
100%
Body Weight
100%
Heparin
100%
Body Mass
50%
Bleeding
50%
Immunology and Microbiology
Body Weight
100%
Capping Phenomenon
100%
Body Mass
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Heparin
100%
Bleeding
50%